F/sup -/
<sup>18</sup>F-fluorodeoxyglucose uptake predicts MET expression in lung adenocarcinoma
... before tumor resection. We found that SUV max was signifi- cantly higher in the MET-positive group than in the MET- negative group (9.92 ± 6.62 vs 4.60 ± 3.00; P = 0.002). Positive correlation was observed between SUV ...
9
<p>The Diagnostic Value Of Using <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography To Differentiate Between Low- And High-Grade Meningioma</p>
... 18 F- fl uorodeoxyglucose positron emission tomography; TGR, tumor to gray ratio; ROC, receiver-oper- ating characteristic; WHO, World Health Organization; PFS, progression-free survival; CNS, central nervous ...
9
<p>Prognostic values of baseline, interim and end-of therapy <sup>18</sup>F-FDG PET/CT in patients with follicular lymphoma</p>
... mid-treatment PET scans for the prediction of PFS and OS. Bishu et al 32 have shown similar results that no sig- ni fi cant difference in PFS between I-PET positive and negative patients. However, in a prospective study ...
15
Differential diagnostic value of <sup>18</sup>F-FDG PET/CT for benign and malignant vertebral compression fractures: comparison with magnetic resonance imaging
... was mostly observed in the region of bone marrow with a relatively high SUV max (Figure 3), and the accumulation pat- tern was nodular, cord-shaped, or irregular. Regarding the benign fractures, “striped” FDG uptake was ...
11
<sup>18</sup>F-fludrodeoxyglucose maximal standardized uptake value and metabolic tumor burden are associated with major chemotherapy-related tumor markers in NSCLC patients
... However, we acknowledge that our study has several shortcomings. First, the nature of data collection was from a single center. Second, this was a retrospective study with a relatively small sample. Third, multiple ...
10
<p>Diagnostic and Predictive Values of <sup>18</sup>F-FDG PET/CT Metabolic Parameters in <em>EGFR</em>-Mutated Advanced Lung Adenocarcinoma</p>
... Although mutational analysis using tumor tissue or body fluid is the standard method for determining EGFR mutational status, it is sometimes limited by issues such as invasiveness of the tissue acquisition procedures and ...
13
Application of Haralick texture features in brain [<sup>18</sup>F]-florbetapir positron emission tomography without reference region normalization
... Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer ...
10
Can <sup>18</sup>F-FDG PET predict the grade of malignancy in thymic epithelial tumors? An evaluation of only resected tumors
... and predicting prognosis in patients with TETs should also be evaluated further. Finally, although our study included more patients with TETs than previous studies, there were still not enough patients for each ...
8
Radiosynthesis and pharmacokinetics of [<sup>18</sup>F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice
... of Health and Family Planning (Number: 2014JP009A), the Three Years Program of Shanghai Municipal Traditional Chinese Medicine (Number: ZY3-CCCX-3-30036), and the Carcinogenesis and Cancer Invasion Laboratory of ...
10
Comparative diagnostic accuracy of <sup>18</sup>F-FDG PET/CT for breast cancer recurrence
... tomography (FDG PET/CT) has been shown to be relevant in the detection and management of breast cancer recurrence in doubtful cases in selected groups of patients. While there are no conclusive data indicating that ...
11
Use of micro-positron emission tomography with <sup>18</sup>F-fallypride to measure the levels of dopamine receptor-D2 and <sup>18</sup>F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats
... According to the groups, all rats were fasted for more than 2 hours prior to the test. PET was performed using a micro- PET scanner (Inveon; Siemens, Munich, Germany) that was equipped with a micro-PET Manager for data ...
12
Synthesis and evaluation of <em>ortho</em>-[<sup>18</sup>F]fluorocelecoxib for COX-2 cholangiocarcinoma imaging
... obtained from the desired fractions after HPLC purification, and 5 µ L (10,000 Bq) was added to each well. After standing for 10 min, the mixture in each well was transferred through pipette to a silica cartridge ...
12
<p>PD-L1 in Lung Adenocarcinoma: Insights into the Role of <sup>18</sup>F-FDG PET/CT</p>
... 18 F-FDG PET/CT (SUVmax/TLG) could be a signi fi cant marker for predicting a worse outcome in PD-L1 -positive but not PD-L1-negative ...18 F-FDG PET/CT may play a role in predicting the prognosis of PD- ...
11
Whole-body MRI versus <sup>18</sup>F-FDG PET/CT for pretherapeutic assessment and staging of lymphoma: a meta-analysis
... comprised a heterogeneous group of lymphoma subtypes with variable FDG avidities, which may potentially con- tribute to the heterogeneity in the indolent group. Thereby, a subgroup analysis was conducted and the patients ...
12
Tobramycin administered by the TOBI<sup>®</sup> Podhaler<sup>®</sup> for persons with cystic fibrosis: a review
... Notes: Gray circles, subjects randomized to receive 112 mg TiP twice daily; black circles, subjects randomized to receive 300 mg TiS twice daily; open circles, subjects randomized to receive matching placebo treatment ...
10
Developments in administration of growth hormone treatment: focus on Norditropin<sup>®</sup> Flexpro<sup>®</sup>
... available in three doses, ie, 5 mg/1.5 mL, 10 mg/1.5 mL, and 15 mg/1.5 mL (Figure 1). The pen device must be refrigerated prior to first use, but after initial use, the pen devices can then either be stored outside of ...
8
Comparison of ultra-widefield fluorescein angiography with the Heidelberg Spectralis<sup>®</sup> noncontact ultra-widefield module versus the Optos<sup>®</sup> Optomap<sup>®</sup>
... Neither the authors nor the Weill Cornell Medical College have any direct or indirect financial interest in any manu- facturer of ultra-widefield imaging devices. No funding of any kind from any company was received to ...
6